Skip to content
JournalsWorldThe Global Research Discovery Platform
Login Sign Up

Academic Journal

Q1

Cancer Nanotechnology

BioMed Central Ltd

United KingdomPharmaceutical Science (Q1); Physical and Theoretical Chemistry (Q1); Biomedical Engineering (Q2); Oncology (Q2)ISSN-matched source record
Submission information ↗
Q1Ranking
5.8Impact Factor (2025)
46H-index (SCImago 2025)
0.849SJR (2025)
2010-2026Coverage

About Cancer Nanotechnology

Cancer Nanotechnology is a scholarly journal published by BioMed Central Ltd. SCImago 2025 lists it in Q1, with an SJR of 0.849 and H-index of 46.

Coverage: 2010-2026. Research categories: Pharmaceutical Science (Q1); Physical and Theoretical Chemistry (Q1); Biomedical Engineering (Q2); Oncology (Q2).

Verified field sources

  • Journal Impact Factor: 5.8 — Official source; checked 2026-10-03. Journal metric year and editorial leadership as listed on the Springer Nature journal homepage.
  • Impact Factor year: 2025 — Official source; checked 2026-10-03. Journal metric year and editorial leadership as listed on the Springer Nature journal homepage.
  • Editor(s): Hao Hong PhD (Editor-in-Chief) — Official source; checked 2026-10-03. Journal metric year and editorial leadership as listed on the Springer Nature journal homepage.

Open-access policies and author information

Reported in the official DOAJ public CSV snapshot (2026-09-01), downloaded 2026-10-03. Record updated 2026-03-17. This snapshot does not establish today’s listing status or fee quotation.

Accepted manuscript languagesEnglish
Licence optionsCC BY, CC BY-NC-ND
Peer-review processAnonymous peer review
APCDOAJ-reported APC: 1790 EUR; 2090 USD; 1490 GBP
Waiver policy reportedYes
Other fees reportedNo
Author retains unrestricted copyrightNo
Digital preservationCLOCKSS, Portico
Reported submission-to-publication time15 weeks on average; not a guarantee
Openly licensed content since2010 (not the journal founding year)

Publisher policy links recorded by DOAJ

Source: DOAJ journal record. Journal metadata is distributed by DOAJ under CC0. Confirm current fees, tax, eligibility and waiver terms with the publisher.

Source-backed journal facts

ISSN(s)1868-6958, 1868-6966
ISSN-L1868-6958
Source typeJournal
Publisher / hosting organisationBioMed Central
Publisher country codeAT
Fully open access (OpenAlex)Yes
DOAJ flag (OpenAlex)Listed in OpenAlex metadata; confirm current status in DOAJ
Works recorded in OpenAlex481
Citations recorded in OpenAlex10,853
OpenAlex H-index51
Years represented in OpenAlex2007–2026 (not the founding or closing dates)

Topics in published research

Nanoparticle-Based Drug Delivery; Nanoplatforms for cancer theranostics; RNA Interference and Gene Delivery; Graphene and Nanomaterials Applications; Advanced biosensing and bioanalysis techniques; Radiation Therapy and Dosimetry.

OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.

Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.

Found incorrect or outdated information?Help us keep this profile accurate.
Suggest an Edit